Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.400
-0.010 (-0.41%)
May 8, 2026, 5:43 PM CET
Biofrontera AG Revenue
In the year 2025, Biofrontera AG had annual revenue of 13.19M EUR with 8.26% growth.
Revenue
13.19M
Revenue Growth
-27.43%
P/S Ratio
1.12
Revenue / Employee
178.23K
Employees
74
Market Cap
14.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.19M | 1.01M | 8.26% |
| Dec 31, 2024 | 12.18M | -20.06M | -62.22% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.07B |
| Fresenius SE & Co. KGaA | 22.99B |
| Merck KGaA | 21.10B |
| Maternus-Kliniken Aktiengesellschaft | 125.58M |
| FamiCord AG | 88.17M |
| MeVis Medical Solutions AG | 16.06M |
| Geratherm Medical AG | 14.29M |